drugset / Trial / NCT02312375
Effects of Fimasartan on Insulin Secretion in Type 2 Diabetic Patients
RandomizedCrossoverOpen-labelTreatment
Summary
This study was designed to evaluate the effect of ARB in improving insulin secretion in patients with type 2 diabetes. The investigators also aimed to evaluate if there are potential synergisms between ARB and DPP4 inhibitors in improving insulin secretion and urinary albumin secretion in diabetic patients.
Timeline
- Start
- 2015-03
- Primary completion
- 2016-12
- Completion
- 2017-03
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Amlodipine | Other / unclassified | — | — |
| Subject | Fimasartan | Small molecule | — | — |